Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pediatr ; 177(9): 1371-1375, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29353440

ABSTRACT

The board game Kaledo was proven to be effective in improving nutrition knowledge and in modifying dietary behavior in students attending middle and high school. The present pilot study aims to reproduce these results in younger students (7-11 years old) attending primary school. A total of 1313 children from ten schools were recruited to participate in the present study. Participants were randomized into two groups: (1) the treatment group which consisted of playing Kaledo over 20 sessions and (2) the no intervention group. Anthropometric measures were carried out for both groups at baseline (prior to any treatment) and at two follow-up post-assessments (8 and 18 months). All the participants completed a questionnaire concerning physical activity and a 1-week food diary at each assessment. The primary outcomes were (i) BMI z-score, (ii) scores on physical activity, and (iii) scores on a dietary questionnaire. BMI z-score was significantly lower in the treated group compared to the control group at 8 months. Frequency and duration of self-reported physical activity were also significantly augmented in the treated group compared to the control group at both post-assessments. Moreover, a significant increase in the consumption of healthy food and a significant decrease in junk food intake were observed in the treated group. CONCLUSION: The present results confirm the efficacy of Kaledo in younger students in primary schools, and it can be used as a useful nutritional tool for obesity prevention programs in children. What is Known: • Kaledo is a new educational board game to improve nutrition knowledge and to promote a healthy lifestyle. • In two cluster randomized trials conducted in Campania region (Italy), we showed that Kaledo could improve nutrition knowledge and dietary behavior and have a positive effect on the BMI z-score in children with age ranging from 9 to 14 years old attending school. • Kaledo may be used as an effective tool for obesity prevention programs in middle and high school students. What is New: • Investigating the effects of Kaledo on younger primary school children (7-11 year olds), Kaledo could be an effective tool in obesity prevention programs for children as young as 7 years old.


Subject(s)
Exercise/physiology , Games, Recreational , Health Promotion/methods , Healthy Lifestyle , Pediatric Obesity/prevention & control , Anthropometry , Child , Eating , Female , Health Behavior/physiology , Humans , Male , Pilot Projects , School Health Services , Schools , Students , Surveys and Questionnaires
2.
Appl Immunohistochem Mol Morphol ; 21(3): 237-41, 2013 May.
Article in English | MEDLINE | ID: mdl-23235344

ABSTRACT

AIM: Thyroid cancer represents the first endocrine malignant neoplasm, accounting for 1% of human malignancy. The majority of which are well-differentiated cancer representing up to 90% of thyroid cancer and pursuing a favorable clinical course. The groups of poorly differentiated thyroid cancer (PDC) and anaplastic thyroid cancer (ATC) have a poor outcome and need a strict clinical surveillance. MATERIALS AND METHODS: Thirty-four cases including 23 PDC/insular cancer and 9 ATC were examined for the expression of an immunohistochemical panel made up by HBME-1, galectin-3, and ß-catenin and correlated either with histologic prognostic parameters or the overall surveillance. RESULTS: HBME-1 and galectin-3 were expressed in 100% of the PDC/insular cases and in none of the ATC cases. The data for ß-catenin pointed out an 80% expression (12/15) in the PDCs and only a focal and nonspecific positivity in the ATCs. A ß-catenin-positive expression was found in all patients with a worse outcome/death and in the presence of vascular invasion and metastatic disease. All 3 PDC patients with ß-catenin negativity are alive, whereas only 41% (5/12) are alive in the ß-catenin-positive group. CONCLUSIONS: Our data set up the idea that PDC represents an intermediate step in the biological process of dedifferentiation of thyroid tumors toward ATC. This shift is underlined by the ß-catenin expression, which seems to be related to a worse prognostic behavior. HBME-1 and galectin-3 show a similar pattern in PDC compared with well-differentiated carcinoma, whereas they are not expressed, as well as ß-catenin, in anaplastic carcinomas.


Subject(s)
Biomarkers, Tumor/genetics , Carcinoma/diagnosis , Galectin 3/genetics , Thyroid Neoplasms/diagnosis , beta Catenin/genetics , Adult , Aged , Carcinoma/genetics , Carcinoma/pathology , Cell Dedifferentiation , Cell Differentiation , Cell Transformation, Neoplastic , Diagnosis, Differential , Female , Gene Expression , Humans , Male , Middle Aged , Prognosis , Thyroid Carcinoma, Anaplastic , Thyroid Neoplasms/genetics , Thyroid Neoplasms/pathology
3.
J Med Chem ; 46(6): 917-20, 2003 Mar 13.
Article in English | MEDLINE | ID: mdl-12620068

ABSTRACT

N-Benzyl- and N-propargyl-1H-pyrrole-2-carboxyamides and some related methylenamines were synthesized and tested for their monoamine oxidase types A and B inhibitory activity. 2-(N-Methyl-N-propargylaminomethyl)-1H-pyrrole (24) was the most potent MAO-A inhibitor of the series [K(i)(MAO-A) = 0.0054 microM], but it was not selective. Inhibitors N-4-fluorobenzyl-1H-pyrrole-2-carboxamide (12) and N-cyclohexylmethyl-1H-pyrrole-2-carboxamide (25) showed the highest MAO-A selectivity indexes (SI) corresponding to 2025 and >2500, respectively, while 2-(N-methyl-N-benzylaminomethyl)-1H-pyrrole (21) was the most selective MAO-B inhibitor, having an SI of 0.0057.


Subject(s)
Alkynes/chemical synthesis , Monoamine Oxidase Inhibitors/chemical synthesis , Monoamine Oxidase/metabolism , Pyrroles/chemical synthesis , Alkynes/chemistry , Alkynes/pharmacology , Amides/chemical synthesis , Amides/chemistry , Amides/pharmacology , Amines/chemical synthesis , Amines/chemistry , Amines/pharmacology , Animals , Brain/enzymology , Brain/ultrastructure , Cattle , Isoenzymes/metabolism , Mitochondria/enzymology , Monoamine Oxidase Inhibitors/chemistry , Monoamine Oxidase Inhibitors/pharmacology , Pyrroles/chemistry , Pyrroles/pharmacology , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...